CytoReason
Provider of cell-based models and data analysis services intended to develop a computational model of the human body that simulates human disease on a cellular level. The company's platform uses a pro...
Valuation
$159.8M
Latest known
Share Price
N/A
Total Raised
$123M
Last Round
N/A